Skip to main content
Top
Published in: Current Hematologic Malignancy Reports 6/2017

01-12-2017 | Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor)

Using Social Media at National Meetings in Hematology—Optimal Use, Tips, Strategies, and Limitations

Author: Aaron C. Logan

Published in: Current Hematologic Malignancy Reports | Issue 6/2017

Login to get access

Abstract

Social media has become an important tool for physicians and scientists to rapidly share information with colleagues around the world. Use of social media outlets—in particular, Twitter—has risen rapidly in recent years, and it is now customary for national hematology meetings to have thousands of participants who share photographs and textual summaries of data presentations, as well as personal insights and commentary, with virtual audiences. These messages, or “tweets,” can be specifically followed using a hashtag ontology which arose organically over the past several years in the context of medical meetings. This system facilitates communication between meeting attendees and those colleagues near and far with similar interests, thus globalizing the conversation between hematology providers, investigators, patient advocates, professional organizations, regulatory agencies, testing companies, and the pharmaceutical industry about cutting-edge developments in the field.
Literature
2.
go back to reference •• Katz MS, Utengen A, Anderson PF, Thompson MA, Attai DJ, Johnston C, et al. Disease-specific hashtags for online communication about cancer care. JAMA Oncol. 2016;2:392–4. Concise description of the origin of disease-specific hashtags and a study describing their initial usage patterns by patients, caregivers/advocates, physicians, non-physician healthcare providers, other individuals, hospitals, other organizations, and spam generators CrossRefPubMed •• Katz MS, Utengen A, Anderson PF, Thompson MA, Attai DJ, Johnston C, et al. Disease-specific hashtags for online communication about cancer care. JAMA Oncol. 2016;2:392–4. Concise description of the origin of disease-specific hashtags and a study describing their initial usage patterns by patients, caregivers/advocates, physicians, non-physician healthcare providers, other individuals, hospitals, other organizations, and spam generators CrossRefPubMed
3.
go back to reference Thompson MA, Majhail NS, Wood WA, Perales M, Chaboissier M. Social media and the practicing hematologist: Twitter 101 for the busy healthcare provider. Curr Hematol Malig Rep. 2016;10:405–12.CrossRef Thompson MA, Majhail NS, Wood WA, Perales M, Chaboissier M. Social media and the practicing hematologist: Twitter 101 for the busy healthcare provider. Curr Hematol Malig Rep. 2016;10:405–12.CrossRef
5.
go back to reference Dahiya S, Kansagara AJ, Ali SS. Increasing use of social media at annual ASH meetings. Blood. 2015;126:4469. Dahiya S, Kansagara AJ, Ali SS. Increasing use of social media at annual ASH meetings. Blood. 2015;126:4469.
6.
go back to reference Pemmaraju N, Thompson MA, Mesa RA, Desai T. Analysis of the use and impact of twitter during American Society of Clinical Oncology Annual Meetings from 2011 to 2016: focus on advanced metrics and user trends. J Oncol Pract. 2017(13):e623–31. Pemmaraju N, Thompson MA, Mesa RA, Desai T. Analysis of the use and impact of twitter during American Society of Clinical Oncology Annual Meetings from 2011 to 2016: focus on advanced metrics and user trends. J Oncol Pract. 2017(13):e623–31.
9.
10.
go back to reference Shore R, Halsey J, Shah K, Crigger BJ, Douglas SP. AMA Council on Ethical and Judicial Affairs (CEJA) report of the AMA Council on Ethical and Judicial Affairs: professionalism in the use of social media. J Clin Ethics. 2011;22:165–72.PubMed Shore R, Halsey J, Shah K, Crigger BJ, Douglas SP. AMA Council on Ethical and Judicial Affairs (CEJA) report of the AMA Council on Ethical and Judicial Affairs: professionalism in the use of social media. J Clin Ethics. 2011;22:165–72.PubMed
11.
go back to reference •• Farnan JM, Snyder Sulmasy L, Worster BK, Chaudry HJ, Rhyne JA, Arora VM, et al. Online medical professionalism: patient and public relationships: policy statement from the American College of Physicians and the Federation of State Medical Boards. Ann Intern Med. 2013;158:620–7. Important professional guidelines for physicians regarding use of online media. CrossRefPubMed •• Farnan JM, Snyder Sulmasy L, Worster BK, Chaudry HJ, Rhyne JA, Arora VM, et al. Online medical professionalism: patient and public relationships: policy statement from the American College of Physicians and the Federation of State Medical Boards. Ann Intern Med. 2013;158:620–7. Important professional guidelines for physicians regarding use of online media. CrossRefPubMed
12.
go back to reference Lewis MA, Dicker AP. Social media and oncology: the past, present, and future of electronic communication between physician and patient. Semin Oncol. 2015;42:764–71.CrossRefPubMedPubMedCentral Lewis MA, Dicker AP. Social media and oncology: the past, present, and future of electronic communication between physician and patient. Semin Oncol. 2015;42:764–71.CrossRefPubMedPubMedCentral
13.
go back to reference Dizon DS, Graham D, Thompson MA, Johnson LJ, Johnston C, Fisch MJ, et al. Practical guidance: the use of social media in oncology. J Oncol Pract. 2012;8:e114–24.CrossRefPubMedPubMedCentral Dizon DS, Graham D, Thompson MA, Johnson LJ, Johnston C, Fisch MJ, et al. Practical guidance: the use of social media in oncology. J Oncol Pract. 2012;8:e114–24.CrossRefPubMedPubMedCentral
Metadata
Title
Using Social Media at National Meetings in Hematology—Optimal Use, Tips, Strategies, and Limitations
Author
Aaron C. Logan
Publication date
01-12-2017
Publisher
Springer US
Published in
Current Hematologic Malignancy Reports / Issue 6/2017
Print ISSN: 1558-8211
Electronic ISSN: 1558-822X
DOI
https://doi.org/10.1007/s11899-017-0427-5

Other articles of this Issue 6/2017

Current Hematologic Malignancy Reports 6/2017 Go to the issue

Acute Myeloid Leukemias (H Erba, Section Editor)

Predicting Chemotherapy Resistance in AML

Acute Myeloid Leukemias (H Erba, Section Editor)

Methods of Detection of Measurable Residual Disease in AML

Acute Myeloid Leukemias (H Erba, Section Editor)

Measurement of Residual Disease in Acute Myeloid Leukemia

Myeloproliferative Neoplasms (B Stein, Section Editor)

Novel Therapies for Myelofibrosis

Acute Myeloid Leukemias (H Erba, Section Editor)

Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia